Sort   by:  
 Page size 
ProteomicsLeptin-deficient Mouse Liver TMT-label Discovery Proteomics Profiling
The aim of this project was to profile the proteome of mouse-derived liver in order to identify those that showed significant quantitative different proteins among leptin-deficient (db/db) mouse, the genetic non-alcoholic fatty liver disease (NAFLD) mouse model and their lean BKS mouse group.
ORGANISM(S): Mus musculus (Mouse) 
2022-10-14 | PXD027938 | Pride
Liver Tmt-lable Lc-ms/ms 
ProteomicsLeptin-deficient Mouse Serum TMT-label Discovery Proteomics Profiling
The aim of this project was to profile the proteome of mouse-derived serum in order to identify those that showed significant quantitative different proteins among leptin-deficient (db/db) mouse, the genetic non-alcoholic fatty liver disease (NAFLD) mouse model and their lean bks mouse group.
ORGANISM(S): Mus musculus (Mouse) 
2022-10-14 | PXD027937 | Pride
Tmt-lable Serum Lc-ms/ms 
ProteomicsProtein Lactylation modification and Proteomics Features in Cirrhosis Patients after MSCs Treatment.
Mesenchymal stem cell (MSC) therapy improves liver function in patients with liver cirrhosis. However, the therapeutic mechanism underlying MSC therapy remains unclear. Therefore, this study aimed to elucidate the therapeutic mechanism underlying MSC therapy by analyzing changes in the modification ...
ORGANISM(S): Homo sapiens (Human) 
2024-01-26 | PXD037530 | Pride
Liver cirrhosis  mesenchymal stem cell  cell therapy  lactylation modification  proteomics analysis. 
Sort   by:  
 Page size